Statistics on Biotechnology Use  
Results by fields of operation
Business Sector Biotechnology indicators by branch of activity.
Unidades: specified in variables

,Total Companies,Services,Industry and Construction,Agriculture,
No. of companies carrying out R&D in Biotechnology,1.299,774,424,101,
%Companies according to biotechnology used: Genetic code,30,8,39,6,16,8,22,4,
%Companies according to biotechnology used: Functional units,38,4,42,6,34,2,23,7,
%Companies according to biotechnology used: Cellular and tissue culturing and engineering,21,5,26,14,3,17,4,
%Companies according to biotechnology used: Bioprocesses,50,8,40,74,7,32,7,
%Companies according to biotechnology used: Sub-cellular organisms,8,5,11,6,4,3,2,1,
%Companies according to biotechnology used: Bio-computing,24,34,5,9,1,6,
%Companies according to biotechnology used: Nanobiotechnology,12,1,16,8,6,1,1,
%Companies according to biotechnology used: Other,16,9,19,8,1,37,6,
Companies in which biotechnology activities are: Main and/or exclusive,559,442,97,21,
Companies in which biotechnology activities are: A secondary line of business,230,129,83,18,
Companies in which biotechnology activities are: A tool necessary for production,510,203,244,63,
%Company by field(s) of ultimate application of biotechnology use: Human Health,45,5,61,2,26,2,6,2,
%Company by field(s) of ultimate application of biotechnology use: Animal Health and Aquaculture,15,5,16,9,11,23,7,
%Company by field(s) of ultimate application of biotechnology use: Food products,32,3,21,7,51,5,32,9,
%Company by field(s) of ultimate application of biotechnology use: Agriculture and forest production,23,8,20,4,21,3,59,8,
%Company by field(s) of ultimate application of biotechnology use: Environment,15,6,16,3,14,9,13,4,
%Company by field(s) of ultimate application of biotechnology use: Industry,13,7,14,6,14,5,4,1,
Personnel in R&D in biotechnology (no. of persons),15.750,9.680,5.035,1.036,
Personnel in R&D in biotechnology (no. of persons): Research personnel,8.379,5.975,2.144,261,
Personnel in R&D in biotechnology (no. of persons): Technical and auxiliary personnel,7.371,3.704,2.891,775,
Personnel in R&D in biotechnology (no. of persons). Women,8.711,5.499,2.773,438,
Personnel in R&D in biotechnology (no. of persons). Women: Research personnel,4.510,3.287,1.119,104,
Personnel in R&D in biotechnology (no. of persons). Women: Technical and auxiliary personnel,4.200,2.212,1.655,333,
Personnel in R&D in biotechnology (FTE),11.528,6,7.260,7,3.657,9,610,1,
Personnel in R&D in biotechnology (FTE): Research personnel,6.342,7,4.531,8,1.631,6,179,3,
Personnel in R&D in biotechnology (FTE): Technical and auxiliary personnel,5.185,9,2.728,8,2.026,3,430,8,
Personnel in R&D in biotechnology (FTE). Women,6.539,7,4.129,4,2.140,4,270,
Personnel in R&D in biotechnology (FTE). Women: Research personnel,3.455,7,2.476,3,905,7,73,7,
Personnel in R&D in biotechnology (FTE). Women: Technical and auxiliary personnel,3.084,1.653,1.234,7,196,3,
Internal expenditure on R&D (thousands of euros),1.038.582,614.188,382.984,41.410,
1) By nature of the expense: Current expenses,940.091,558.041,344.917,37.132,
1.1) Remuneration to research personnel,321.570,213.833,98.160,9.577,
1.2) Remuneration to technicians and auxiliary personnel,194.836,94.194,87.790,12.851,
1.3) Other current expenses,423.685,250.013,158.967,14.704,
2) By nature of the expense: Capital expenses,98.492,56.147,38.067,4.278,
2.1) Land and buildings,10.199,6.083,2.952,1.165,
2.2) Equipment and instruments,72.584,38.296,32.431,1.858,
2.3) Acquisition of specific R&D software,5.721,3.732,1.850,138,
2.4) Otros productos de propiedad intelectual específicos para I+D,9.987,8.037,833,1.117,
1.1) By origin of the funds: Own funds,711.488,359.197,316.843,35.448,
1.2) By origin of the funds: From companies,121.738,107.930,9.208,4.600,
1.3) By origin of the funds: Public Administration funds,107.477,91.272,14.871,1.334,
1.4) By origin of the funds: From Universities,192,182,11,0,
1.5) By origin of the funds: From non profit private institutions,10.756,10.585,171,0,
1.6) By origin of the funds: Foreign funds,86.931,45.023,41.880,27,
Purchase of R&D services in biotechnology (thousands of euros),145.557,74.421,70.048,1.088,
Purchase of R&D services in biotechnology (thousands of euros): In Spain,95.915,52.406,42.780,729,
Purchase of R&D services in biotechnology (thousands of euros): Abroad,49.642,22.015,27.268,359,
%Companies that consider the following obstacles as very important considering biotechnology development: Access to capital,40,2,48,8,28,25,5,
%Companies that consider the following obstacles as very important considering biotechnology development: Access to technology / information,13,2,13,14,2,10,2,
%Companies that consider the following obstacles as very important considering biotechnology development: Access to human resources,19,20,3,17,3,16,3,
%Companies that consider the following obstacles as very important considering biotechnology development: Disconnection from the value chain,11,5,11,5,11,4,12,1,
%Companies that consider the following obstacles as very important considering biotechnology development: Lack of access to international markets,15,9,18,12,5,13,4,
%Companies that consider the following obstacles as very important considering biotechnology development: Lack of distribution and sales channels,17,20,3,11,3,15,3,
%Companies that consider the following obstacles as very important considering biotechnology development: Acceptance / public perception,16,4,16,5,16,5,16,1,
%Companies that consider the following obstacles as very important considering biotechnology development: Legal and regulatory requirements,40,5,42,9,37,1,36,7,
%Companies that consider the following obstacles as very important considering biotechnology development: Time / cost,55,58,7,48,7,52,9,
%Companies that consider the following obstacles as very important considering biotechnology development: Difficulty accessing patenting,21,9,22,3,20,1,26,3,
% Companies with income of an international origin related to biotechnological activities,23,5,26,2,22,4,7,2,
% Turnover representing income of an international origin related to biotechnological activities,1,9,4,1,1,6,2,2,
% Income of an international origin related to biotechnological activities distributed in: Income received from the EU,61,6,62,4,61,2,68,3,
% Income of an international origin related to biotechnological activities distributed in: Income received from other countries,38,4,37,6,38,8,31,7,
% Income of an international origin related to biotechnological activities by classification: Internacional trade in products and services,87,6,83,2,89,1,85,
% Income of an international origin related to biotechnological activities by classification: Milestones, royalties, sale or licensing of technologies outside Spain,10,9,12,2,10,8,0,
% Income of an international origin related with activities according to the classification: Operating source abroad,1,1,4,3,0,1,0,
% Income of an international origin related with activities according to the classification: Other,0,4,0,3,0,15,
Notas:
'.'=numeric piece of data equal to zero not resulting from rounding 

 FTE: Full Time Equivalent
Fuente: National Statistics Institute